Timetable accelerated assessment request for initial marketing authorisation applications
Management Board meeting: 3 October 2024, European Medicines Agency, Amsterdam, the Netherlands, 3 October 2024
Minutes of the 125th meeting of the EMA Management Board
Parallel scientific advice processes
CHMP work plan 2025
New EU rules for health technology assessments become effective
Health technology assessment bodies
EudraVigilance eXtended Medicinal Product Dictionary (XEVMPD) - Authorisation status
Electronic submission of Article 57(2) data: questions and answers
Chapter 5: eXtended EudraVigilance Product Report Acknowledgement Message - Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the EMA